Dory Freeman
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Surgery 14
- Bladder and Urothelial Cancer Treatments 14
- Urinary and Genital Oncology Studies 7
-
- Ferroptosis and cancer prognosis 3
- Renal cell carcinoma treatment 3
- Prostate Cancer Treatment and Research 3
- Co-authors
- Guru Sonpavde (20 shared papers)Catherine Curran (12 shared papers)Amin H. Nassar (9 shared papers)Pier Vitale Nuzzo (8 shared papers)Sarah Abou Alaiwi (5 shared papers)Elio Adib (12 shared papers)Toni K. Choueiri (9 shared papers)Praful Ravi (11 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Clinical Genitourinary Cancer (4 papers)Clinical Cancer Research (1 paper)The Oncologist (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Dory Freeman
21 papers receiving 115 citations
Peers
Comparison fields: 5 of 23
- Pulmonary and Respiratory Medicine 34
- Oncology 25
- Surgery 35
- Cancer Research 10
- Applied Microbiology and Biotechnology 1
Countries citing papers authored by Dory Freeman
This map shows the geographic impact of Dory Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dory Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dory Freeman more than expected).
Fields of papers citing papers by Dory Freeman
This network shows the impact of papers produced by Dory Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dory Freeman. The network helps show where Dory Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Dory Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 19 | |
| 2 | 2021 | 13 | |
| 3 | 2021 | 13 | |
| 4 | 2024 | 11 | |
| 5 | 2012 | 10 | |
| 6 | 2021 | 8 | |
| 7 | 2022 | 7 | |
| 8 | 2024 | 5 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2022 | 1 |
About Dory Freeman
Dory Freeman is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Molecular Biology, having authored 25 papers that have together received 115 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Genomics and Diagnostics (4 papers), Ferroptosis and cancer prognosis (3 papers), Renal cell carcinoma treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (34 citations), Oncology (25 citations), Surgery (35 citations), Cancer Research (10 citations) and Applied Microbiology and Biotechnology (1 citation). Dory Freeman has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include Guru Sonpavde, Catherine Curran, Amin H. Nassar, Pier Vitale Nuzzo, Sarah Abou Alaiwi, Elio Adib, Toni K. Choueiri, Praful Ravi, William Paul Skelton and Rakesh K. Jain. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Clinical Cancer Research, The Oncologist and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.